Skip to content

CardioGenics Holdings Inc.: 10-Q/A filed 2011-09-23

What CardioGenics Holdings Inc. reported in its quarterly report amendment filed 2011-09-23 (fiscal Q3 2011): 28 published measures, 88 facts as tagged in accession 0001144204-11-054492.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2011-09-23
Fiscal period
fiscal Q3 2011
Accession
0001144204-11-054492 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CardioGenics Holdings Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-07-311,465,986USD
At 2010-10-312,486,135USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-07-31-465,108USD
At 2010-10-312,198,176USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-07-311,117,644USD
At 2010-10-311,844,752USD
At 2010-07-31767,458USD
At 2009-10-312,388,516USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-2,172,370USD92
2010-11-01 to 2011-07-31-3,391,101USD273
1997-11-20 to 2011-07-31-38,397,657USD5002
2010-05-01 to 2010-07-31-684,940USD92
2009-11-01 to 2010-07-31-1,507,638USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2010-11-01 to 2011-07-31-1,008,504USD273
1997-11-20 to 2011-07-31-5,865,776USD5002
2009-11-01 to 2010-07-31-1,545,568USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2010-11-01 to 2011-07-3112,772USD273
1997-11-20 to 2011-07-31217,196USD5002

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-05-01 to 2011-07-316,400USD92
2010-11-01 to 2011-07-316,400USD273
1997-11-20 to 2011-07-316,400USD5002

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2010-11-01 to 2011-07-31326,495USD273
1997-11-20 to 2011-07-317,359,966USD5002
2009-11-01 to 2010-07-31-41,601USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2010-11-01 to 2011-07-31-12,772USD273
1997-11-20 to 2011-07-31-318,117USD5002
2009-11-01 to 2010-07-31-17,813USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-07-3185,300USD
At 2010-10-3187,465USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
1997-11-20 to 2011-07-312,508,282USD5002

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-2,173,419USD92
2010-11-01 to 2011-07-31-3,259,299USD273
1997-11-20 to 2011-07-31-23,864,314USD5002
2010-05-01 to 2010-07-31-665,786USD92
2009-11-01 to 2010-07-31-1,444,456USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-07-311,213,205USD
At 2010-10-312,227,967USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-07-312,231,846USD
At 2010-10-31559,296USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-07-316,400USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-05-01 to 2011-07-312,179,819USD92
2010-11-01 to 2011-07-313,265,699USD273
1997-11-20 to 2011-07-3123,870,714USD5002
2010-05-01 to 2010-07-31665,786USD92
2009-11-01 to 2010-07-311,444,456USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-05-01 to 2011-07-31141,206USD92
2010-11-01 to 2011-07-31534,776USD273
1997-11-20 to 2011-07-313,822,527USD5002
2010-05-01 to 2010-07-31208,279USD92
2009-11-01 to 2010-07-31520,964USD273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-07-3138,052,250USD
At 2010-10-3137,441,728USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-07-31-120,224USD
At 2010-10-31-237,508USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-07-31-780,180USD
At 2010-10-311,905,954USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2011-07-31167,481USD
At 2010-10-31170,703USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-2,187,008USD92
2010-11-01 to 2011-07-31-3,413,951USD273
1997-11-20 to 2011-07-31-38,712,729USD5002
2010-05-01 to 2010-07-31-689,904USD92
2009-11-01 to 2010-07-31-1,518,608USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-05-01 to 2011-07-31278,314USD92
2010-11-01 to 2011-07-31958,963USD273
1997-11-20 to 2011-07-315,148,693USD5002
2010-05-01 to 2010-07-31455,072USD92
2009-11-01 to 2010-07-31904,694USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-05-01 to 2011-07-315,409USD92
2010-11-01 to 2011-07-3114,938USD273
1997-11-20 to 2011-07-31195,978USD5002
2010-05-01 to 2010-07-311,431USD92
2009-11-01 to 2010-07-3115,778USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-05-01 to 2011-07-311,090USD92
2010-11-01 to 2011-07-313,222USD273
1997-11-20 to 2011-07-3110,426USD5002
2010-05-01 to 2010-07-311,004USD92
2009-11-01 to 2010-07-313,020USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-05-01 to 2011-07-31-13,589USD92
2010-11-01 to 2011-07-31-154,652USD273
1997-11-20 to 2011-07-31-14,810,704USD5002
2010-05-01 to 2010-07-31-24,118USD92
2009-11-01 to 2010-07-31-126,848USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-11-01 to 2011-07-31359,411USD273
1997-11-20 to 2011-07-315,635,833USD5002
2009-11-01 to 2010-07-3177,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2010-11-01 to 2011-07-316,400USD273
1997-11-20 to 2011-07-316,400USD5002

Inspect the source

Entity
CardioGenics Holdings Inc. / CIK 0001089029
Captured
SEC response SHA-256
fc1d26b5dc66df3e12f4b0071eebc7f92b6a2feccc83acfb92e8a5959410b4c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001089029.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))